WYETH for WYETH
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Pharmaceutical drug importation S. Con Res 21 FY 2008 Senate Budget Resolution
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEO C JARDOT | VICE PRESIDENT, GOVERNMENT RELATIONS |
| BRONWEN KAYE | SENIOR DIRECTOR, GOVERNMENT RELATIONS |
| JULIE RABINOWITZ | SENIOR DIRECTOR & COUNSEL, GVT RELATIONS |
| ANGELA WALKER RIEMER | SENIOR DIRECTOR, GOVERNMENT RELATIONS |
Trade (domestic/foreign) TRD
Monitor U.S. trade policies relating to intellectual property protection under the WTO TRIPS agreement Importation of FDA-approved pharmaceuticals
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEO C JARDOT | VICE PRESIDENT, GOVERNMENT RELATIONS |
| BRONWEN KAYE | SENIOR DIRECTOR, GOVERNMENT RELATIONS |
| JULIE RABINOWITZ | SENIOR DIRECTOR & COUNSEL, GVT RELATIONS |
| ANGELA WALKER RIEMER | SENIOR DIRECTOR, GOVERNMENT RELATIONS |
Taxation/Internal Revenue Code TAX
Puerto Rico Tax Incentives; Taxation of International Operations of U.S. corporations generally R&D Tax Credit; Taxation of Deferred Compensation Plans; Homeland Investment legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEO C JARDOT | VICE PRESIDENT, GOVERNMENT RELATIONS |
| BRONWEN KAYE | SENIOR DIRECTOR, GOVERNMENT RELATIONS |
| JULIE RABINOWITZ | SENIOR DIRECTOR & COUNSEL, GVT RELATIONS |
| ANGELA WALKER RIEMER | SENIOR DIRECTOR, GOVERNMENT RELATIONS |
Copyright/Patent/Trademark CPT
Monitor U.S. trade policies relating to intellectual property protection under the WTO TRIPS agreement H.R. 1908 Patent Reform Act of 2007 S. 1145 Patent Reform Act of 2007
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEO C JARDOT | VICE PRESIDENT, GOVERNMENT RELATIONS |
| BRONWEN KAYE | SENIOR DIRECTOR, GOVERNMENT RELATIONS |
| JULIE RABINOWITZ | SENIOR DIRECTOR & COUNSEL, GVT RELATIONS |
| ANGELA WALKER RIEMER | SENIOR DIRECTOR, GOVERNMENT RELATIONS |
Health Issues HCR
Issues relating to support of Office of Women's Health and Public Education Initiatives Childhood immunizations Dietary supplement issues FDA reform issues Medicare reimbursement for certain drugs Importation Implementation issues concerning P.L. 108-173 - The Medicare Prescription Drug, Improvement and Modernization Act of 2003 Follow developments within the Bush Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies Drug Compounding Alzheimer's care H.R. 2900 Food and Drug Administration Act of 2007 S.1695 Biologics Price Compeition and Innovation Act of 2007 Issues related to hormone therapy H.R. 3043 Labor/HHS Appropriations Act of 2008 S. 1276 Methamphetamine Production Prevention Act of 2007 S.1082 FDA Revitalization Act of 2007 H.R. 1812 Menopausal Hormone Replacement Therapies and Alternative Treatments and Fairness Act Pediatric Studies and Trials Follow-on Biologics Drug Importation and Counterfeiting Prescription Drug User Fees Drug Safety/Clinical Trials Vaccine Injury Compensation Program Follow developments within the Bush Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEO C JARDOT | VICE PRESIDENT, GOVERNMENT RELATIONS |
| BRONWEN KAYE | SENIOR DIRECTOR, GOVERNMENT RELATIONS |
| JULIE RABINOWITZ | SENIOR DIRECTOR & COUNSEL, GVT RELATIONS |
| ANGELA WALKER RIEMER | SENIOR DIRECTOR, GOVERNMENT RELATIONS |
Consumer Issues/Safety/Products CSP
S. 1276 Methamphetamine Production Prevention Act of 2007 H.R. 970 DXM Distribution Act S.1378 DXM Distribution Act FDA reform proposals; Pseudoephedrine;
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEO C JARDOT | VICE PRESIDENT, GOVERNMENT RELATIONS |
| BRONWEN KAYE | SENIOR DIRECTOR, GOVERNMENT RELATIONS |
| JULIE RABINOWITZ | SENIOR DIRECTOR & COUNSEL, GVT RELATIONS |
| ANGELA WALKER RIEMER | SENIOR DIRECTOR, GOVERNMENT RELATIONS |
Medicare/Medicaid MMM
Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Issues relating to Medicaid reimbursement for drugs/biologics in Title VI of S.1932-the Deficit Reduction Act of 2005 Pediatric Exclusivity H.R. 4 Medicare Prescription Drug Prie Negoation Act Prescription drug user fees; Methamphetamines Vaccines
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEO C JARDOT | VICE PRESIDENT, GOVERNMENT RELATIONS |
| BRONWEN KAYE | SENIOR DIRECTOR, GOVERNMENT RELATIONS |
| JULIE RABINOWITZ | SENIOR DIRECTOR & COUNSEL, GVT RELATIONS |
| ANGELA WALKER RIEMER | SENIOR DIRECTOR, GOVERNMENT RELATIONS |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.